Send feedback

EPB41 p.Pro291Ser

c.871C>T · rs142874233 · VCV618089

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 7 submitters
AlphaMissense
likely pathogenic
0.7862 · ACMG-weighted
gnomAD v4.1
Rare
low-frequency (popmax 1.99%, mid)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
elliptocytosis 1

Computational evidence

Protein change
AlphaMissense0.7862likely pathogenic
REVEL0.427indeterminate
SaProtLLR -12.54damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.6GERP 2.8, phastCons 1
Regional constrainto/e 0.90unconstrained · MANE · 31 kb · p 0.042 · regional, not allelic
Overall
CADD25.7PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 1.99% Middle Eastern · 120/6,022 alleles
Filtering AF 1.7% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.59%
Overall 0.569% 9,158/1,608,302 alleles · low-frequency
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 5.57% 18
Middle Easterngrpmax 1.99% 50
Remaining individualsnot grpmax-eligible 0.904% 111
South Asian 0.609% 164
European (non-Finnish) 0.507% 197
Admixed American 0.238% 419
African / African-American 0.132% 757
Finnishnot grpmax-eligible 0.119% 842
East Asian 0.00446% 22,401

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EPB41
Protein
p.Pro291Ser
Coding
c.871C>T
MANE Select
NM_001376013
dbSNP
rs142874233
Type
single nucleotide variant
Location
chr1:29015733 (GRCh38)
Gene constraint
LOEUF 0.738 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 63.72 · 3 PDB
Residue 291
the ferm domain
Full EPB41 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

elliptocytosis 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Hereditary elliptocytosis (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive
Onset
All ages
Prevalence
1-5 / 10 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/epb41-p-pro291ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown